Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design of the DANAMI 3 trial program.

Høfsten DE, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Clemmensen P, Torp-Pedersen C, Tilsted HH, Bøtker HE, Jensen LO, Køber L, Engstrøm T; DANAMI 3 Investigators.

Am Heart J. 2015 May;169(5):613-21. doi: 10.1016/j.ahj.2015.02.004. Epub 2015 Feb 14.

PMID:
25965708
2.

Quantitative myocardial perfusion by O-15-water PET: individualized vs. standardized vascular territories.

Thomassen A, Petersen H, Johansen A, Braad PE, Diederichsen AC, Mickley H, Jensen LO, Gerke O, Simonsen JA, Thayssen P, Høilund-Carlsen PF.

Eur Heart J Cardiovasc Imaging. 2015 May 5. pii: jev111. [Epub ahead of print]

PMID:
25944051
3.

Very late stent thrombosis caused by neoatherosclerotic plaque rupture.

Hougaard M, Thayssen P, Hansen HS, Jensen LO.

EuroIntervention. 2015 Apr 22;10(12):e1-3. doi: 10.4244/EIJV10I12A251. No abstract available.

4.

Underuse of an invasive strategy for patients with diabetes with acute coronary syndrome: a nationwide study.

Gustafsson I, Hvelplund A, Hansen KW, Galatius S, Madsen M, Jensen JS, Tilsted HH, Terkelsen CJ, Jensen LO, Jørgensen E, Madsen JK, Abildstrøm SZ.

Open Heart. 2015 Feb 6;2(1):e000165. doi: 10.1136/openhrt-2014-000165. eCollection 2015.

5.

A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial).

Maeng M, Baranauskas A, Christiansen EH, Kaltoft A, Holm NR, Krusell LR, Ravkilde J, Tilsted HH, Thayssen P, Jensen LO.

Catheter Cardiovasc Interv. 2015 Jan 30. doi: 10.1002/ccd.25875. [Epub ahead of print]

PMID:
25640050
6.

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.

Raungaard B, Jensen LO, Tilsted HH, Christiansen EH, Maeng M, Terkelsen CJ, Krusell LR, Kaltoft A, Kristensen SD, Bøtker HE, Thuesen L, Aarøe J, Jensen SE, Villadsen AB, Thayssen P, Veien KT, Hansen KN, Junker A, Madsen M, Ravkilde J, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT).

Lancet. 2015 Apr 18;385(9977):1527-35. doi: 10.1016/S0140-6736(14)61794-3. Epub 2015 Jan 16. Erratum in: Lancet. 2015 Apr 18;385(9977):1510.

PMID:
25601789
7.

Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark.

Jabbari R, Engstrøm T, Glinge C, Risgaard B, Jabbari J, Winkel BG, Terkelsen CJ, Tilsted HH, Jensen LO, Hougaard M, Chiuve SE, Pedersen F, Svendsen JH, Haunsø S, Albert CM, Tfelt-Hansen J.

J Am Heart Assoc. 2015 Jan 5;4(1):e001399. doi: 10.1161/JAHA.114.001399.

8.

Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

Olesen KK, Tilsted HH, Jensen LO, Kaltoft A, Krusell LR, Ravkilde J, Christiansen EH, Madsen M, Thayssen P, Sørensen HT, Lassen JF, Maeng M.

Am J Cardiol. 2015 Feb 1;115(3):298-302. doi: 10.1016/j.amjcard.2014.10.038. Epub 2014 Nov 11.

PMID:
25499925
9.

Large coronary intramural hematomas: a case series and focused literature review.

Antonsen L, Thayssen P, Jensen LO.

Cardiovasc Revasc Med. 2015 Mar;16(2):116-123. doi: 10.1016/j.carrev.2014.10.009. Epub 2014 Oct 31. Review.

PMID:
25497372
10.

Impact of health care system delay in patients with ST-elevation myocardial infarction on return to labor market and work retirement.

Laut KG, Hjort J, Engstrøm T, Jensen LO, Tilsted Hansen HH, Jensen JS, Pedersen F, Jørgensen E, Holmvang L, Pedersen AB, Christensen EF, Lippert F, Lang-Jensen T, Jans H, Hansen PA, Trautner S, Kristensen SD, Lassen JF, Lash TL, Clemmensen P, Terkelsen CJ.

Am J Cardiol. 2014 Dec 15;114(12):1810-6. doi: 10.1016/j.amjcard.2014.09.018. Epub 2014 Sep 28.

PMID:
25438906
11.

Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.

Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, Agostoni P, Appelman Y, Arslan F, Barbato E, Chen SL, Di Serafino L, Domínguez-Franco AJ, Dupouy P, Esen AM, Esen OB, Hamilos M, Iwasaki K, Jensen LO, Jiménez-Navarro MF, Katritsis DG, Kocaman SA, Koo BK, López-Palop R, Lorin JD, Miller LH, Muller O, Nam CW, Oud N, Puymirat E, Rieber J, Rioufol G, Rodés-Cabau J, Sedlis SP, Takeishi Y, Tonino PA, Van Belle E, Verna E, Werner GS, Fearon WF, Pijls NH, De Bruyne B, Gould KL.

J Am Coll Cardiol. 2014 Oct 21;64(16):1641-54. doi: 10.1016/j.jacc.2014.07.973.

12.

Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.

Thim T, Johansen MB, Chisholm GE, Schmidt M, Kaltoft A, Sørensen HT, Thuesen L, Kristensen SD, Bøtker HE, Krusell LR, Lassen JF, Thayssen P, Jensen LO, Tilsted HH, Maeng M.

BMC Cardiovasc Disord. 2014 Aug 13;14:100. doi: 10.1186/1471-2261-14-100.

13.

Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.

Jensen LO, Thayssen P, Maeng M, Christiansen EH, Ravkilde J, Hansen KN, Kaltoft A, Tilsted HH, Madsen M, Lassen JF; Scandinavian Organization for Randomized Trials With Clinical Outcome SORT OUT IV Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):840-8. doi: 10.1016/j.jcin.2014.02.014. Epub 2014 Jul 30.

PMID:
25086842
14.

Peri-stent contrast staining, major evaginations and severe malapposition after biolimus-eluting stent implantation: a case report based on coronary optical frequency domain imaging.

Antonsen L, Thayssen P, Jensen LO.

Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):424-7. doi: 10.1016/j.carrev.2014.04.006. Epub 2014 Apr 26.

PMID:
24880913
15.

24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.

Würtz M, Hvas AM, Jensen LO, Kaltoft AK, Tilsted HH, Kristensen SD, Grove EL.

Int J Cardiol. 2014 Aug 1;175(2):274-9. doi: 10.1016/j.ijcard.2014.05.013. Epub 2014 May 16.

PMID:
24861258
16.

Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.

Thayssen P, Lassen JF, Jensen SE, Hansen KN, Hansen HS, Christiansen EH, Junker A, Ravkilde J, Thuesen L, Veien KT, Jensen LO.

Circ Cardiovasc Interv. 2014 Apr;7(2):216-24. doi: 10.1161/CIRCINTERVENTIONS.113.000653. Epub 2014 Apr 8.

17.

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Maeng M, Tilsted HH, Jensen LO, Krusell LR, Kaltoft A, Kelbæk H, Villadsen AB, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Thuesen L, Madsen M, Thayssen P, Sørensen HT, Lassen JF.

Lancet. 2014 Jun 14;383(9934):2047-56. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14.

PMID:
24631162
18.

Impact of renal insufficiency on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Sabroe JE, Thayssen P, Antonsen L, Hougaard M, Hansen KN, Jensen LO.

BMC Cardiovasc Disord. 2014 Feb 7;14:15. doi: 10.1186/1471-2261-14-15.

19.

Immediate mobilization after coronary angiography or percutaneous coronary intervention following hemostasis with the AngioSeal vascular closure device (the MOBS study).

Larsen EN, Hansen CB, Thayssen P, Jensen LO.

Eur J Cardiovasc Nurs. 2014 Oct;13(5):466-72. doi: 10.1177/1474515113516702. Epub 2013 Dec 13.

PMID:
24336239
20.

Sex and percutaneous coronary intervention.

Christiansen EH, Jensen LO.

Lancet. 2013 Dec 7;382(9908):1864-5. doi: 10.1016/S0140-6736(13)62030-9. No abstract available.

PMID:
24315165
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk